In 2014, eleven Ebola virus infected patients were hospitalized in the United States. Some of these Ebola infected patients were treated with blood serum obtained from patients that had survived the Ebola virus infection . What was the rationale for using this serum? This blood serum contains anti-Ebola virus antibodies produced by the Ebola virus infection survivors. These antibodies may help the patient fight the Ebola infection. The blood serum of an individual that survived the Ebola virus infection contains B cells and T cells, which may help the patient fight the Ebola infection. This serum acts as a vaccine against Ebola because the Ebola virus infection survivors carry attenuated Ebola viruses. This serum is rich in natural killer cells, which may help the patient fight the Ebola infection.
In 2014, eleven Ebola virus infected patients were hospitalized in the United States. Some of these Ebola infected patients were treated with blood serum obtained from patients that had survived the Ebola virus infection
. What was the rationale for using this serum?
This blood serum contains anti-Ebola virus antibodies produced by the Ebola virus infection survivors. These antibodies may help the patient fight the Ebola infection.
The blood serum of an individual that survived the Ebola virus infection contains B cells and T cells, which may help the patient fight the Ebola infection.
This serum acts as a vaccine against Ebola because the Ebola virus infection survivors carry attenuated Ebola viruses.
This serum is rich in natural killer cells, which may help the patient fight the Ebola infection.
Trending now
This is a popular solution!
Step by step
Solved in 3 steps